The Health Policy Partnership

Tweet this page
<
2016
2017
2018
2019
2020
2022
>
Registration as it was on 05 Jan 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

150,000€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

1.5 Fte (5)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    The Health Policy Partnership   (HPP)

    EU Transparency Register

    223430420230-66 First registered on 08 Jan 2016

    Goals / Remit

    We are a specialist health policy consultancy.
    We create innovative policy initiatives and powerful evidence–based communications for organisations across the health spectrum. We provide a unique, seamless approach to help resolve the most complex issues facing our health care systems.

    We do this through rigorous research and expert synthesis of evidence, inter-sectoral collaboration, and powerful communications that act as the starting point for meaningful changes in policy and practice.

    Main EU files targeted

    We worked closely with many of the MEPs who initiated Written Declaration 110/2016 on Heart Failure (Oct'16 - Jan '17), providing support to a broader public campaign over that period to raise awareness of the Declaration to all MEPs and to other supporters (e.g. NGOs) across Europe.

    Beyond WD 110/2016, we work with several MEPs who have donated their time for free to support (and act as Members of) the Heart Failure Policy Network (HFPN). For more details of the Network's history and activities in 2017 please see www.hfpolicynetwork.eu.

    Address

    Head Office
    The Health Policy Partnership
    68-69 St Martin's Lane
    London WC2N 4JS
    UNITED KINGDOM
  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    50%1
    25%4

    Lobbyists (Full time equivalent)

    1.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Time provided above relates to HPP staff time dedicated to any formal engagement with MEPs, EU officials, or where there is policy activity directly involving or targeting EU institutions - i.e. it excludes general health policy activities where other audiences are our primary targets (e.g. national policy makers, academic experts, clinicians, health providers etc), and global activities.

    Person in charge of EU relations

    Mr Edward Harding (Managing Director)

    Person with legal responsibility

    Mr Harding Ed (Managing Director)

  • Categories

    Category

    I - Professional consultancies/law firms/self-employed consultants

    Subcategory

    Professional consultancies

  • Networking

    Affiliation

    Heart Failure Policy Network - www.hfpolicynetwork.eu
    (provide secretariat and lead project)

    Knowledge partner for European Cancer Patients Coalition (www.ecpc.org) and the Coalition to Eradicate Viral Hepatitis from Asia Pacific (www.cevhap.org)

    Expert member of the European Institute for Women's Health (www.eurohealth.ie)

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    150,000€

    Other financial info

    Some of the funding declared above was received as consultancy fees.

    Funding for the role of the Health Policy Partnership as secretariat for the Heart Failure Policy Network was in the form of a grant from Novartis Pharma and St Jude Medical.

    Declared lobby clients

    Client Name Amount
    Bristol Myers Squibb 10,000€ - 24,999€
    ELI LILLY 10,000€ - 24,999€
    European Cancer Patients Coalition 10,000€ - 24,999€
    Novartis Pharma AG 50,000€ - 99,999€
    St Jude Medical 10,000€ - 24,999€
  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Other activities

    For clarity we mention here previous (i.e. lapsed) projects or parallel workstreams in the health policy sphere that are of note, and/or do not involve any formal engagement or activity with EU institutions.

    1. Development of the Immuno-Oncology Action Framework with the Expert Group on Immuno-Oncology, in partnership with the European Cancer Patients Coalition, with MEP involvement - see www.healthpolicypartnership.com/io

    2. Collaboration with European Cancer Patients Coalition to build an information portal on cancer immunotherapy - http://iop.ecpc.org/

    3. International environmental scan on person-centred care, in partnership with the Health Foundation - http://www.healthpolicypartnership.com/example-work/person-centred-care/

    4. Development of a European policy atlas on the prevention of AF-related stroke - www.healthpolicypartnership.com/af

    5. Launch of a Policy Toolkit on Diabetes in partnership with International Diabetes Federation Europe - www.healthpolicypartnership.com/expand

    6. Facilitation of policy workshops on viral hepatitis in partnership with the Coalition to Eradicate Viral Hepatitis from Asia Pacific (CEVHAP) as well as other hepatitis multistakeholder platforms, leading to several publications

    7. Development of a policy checklist on sarcoma, working with a multi-disciplinary expert group (see www.healthpolicypartnership.com for more information)

    8. Secretariat for a multi-sector platform looking at improving the efficiency of cancer care (All.Can - see www.healthpolicypartnership.com for more information)

    9. Other publications and policy analysis on different health topics, see: www.healthpolicypartnership.com/publications

  • Meetings

    Meetings

    None declared

Download this datacard